Feb 052016

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– AUSTRALIA, Hornsby – Novogen Limited (ASX:NRT; NASDAQ: NVGN), the Australian-US drug discovery and development company, announced today the appointment of a new Chairman, Mr John O'Connor, and new Deputy Chairman, Mr Bryce Carmine, effective immediately.

Incoming CEO, Dr James Garner, has also been formally appointed to the Board as an Executive Director and former Acting CEO, Mr Iain Ross, will resume his role on the Board as a Non-Executive Director.… => more

Novogen updates its Corporate Governance

From:: Novogen updates its Corporate Governance

Sorry, the comment form is closed at this time.